Arash Aminian Baghai

Counsel
Los Angeles
  • 355 South Grand Avenue, Suite 100
  • Los Angeles, CA 90071-1560
  • USA
Profile Experience

Arash Aminian Baghai is counsel in the Los Angeles office of Latham & Watkins. Mr. Aminian Baghai is a corporate finance and securities law attorney, and his practice specializes in complex equity derivative transactions. Mr. Aminian Baghai has advised clients on:

  • Capital markets transactions, including initial public offerings, follow-on offerings of convertible debt, straight debt, and equity, contingent equity facilities, and equity forward transactions
  • Structuring unique securities products, such as mandatorily convertible equity units and “common-tracking” preferred, including in connection with business combination transactions
  • Debt and capital restructuring transactions, including tender and exchange offers, accelerated share repurchases, and stock splits
  • Disclosure and reporting obligations under U.S. federal securities laws
  • Corporate governance matters, including Sarbanes-Oxley Act compliance
  • Listed company obligations under stock exchange rules

 

Mr. Aminian Baghai’s transactional representations include:*

  • MetLife, Inc. in its US$15.5 billion acquisition of the ALICO division of AIG
  • Eli Lilly in its US$2.5 billion public offering of unsubordinated notes, US$1.5 billion private offering of floating rate notes, and US$1.5 billion private offering of floating rate extendible notes
  • BNY Mellon Capital Markets in the establishment of Westar Energy’s US$500 million equity shelf program with an equity forward purchase option, the first transaction of its kind within the energy sector
  • The underwriters of Conceptus, Incorporation’s US$75 million public offering of convertible senior notes with a call spread overlay
  • Omnicare, Inc. in its US$390 million Section 4(2) exchange of existing convertible notes for newly issued convertible notes and the implementation of a related capped call transaction
  • Central European Media Enterprises Ltd. in its US$206 million Section 3(a)(9) exchange of existing convertible notes for newly issued convertible notes
  • Prudential Retirement in the establishment of longevity swap transactions with Deutsch Bank and Rothesay Life, a wholly owned subsidiary of The Goldman Sachs Group, Inc., covering pension liabilities aggregating over £950 million
  • Aspen Insurance Holdings Limited in its US$200 million collared accelerated stock buyback
  • MedImmune, Inc. in its US$1 billion Rule 144A offering of convertible senior notes with a call spread overlay
  • Accredited Mortgage Loan REIT Trust in its offering of perpetual cumulative preferred shares in a transaction pursuant to which Accredited became an SEC-reporting company
  • The underwriters of the initial public offerings of Ribapharm Inc., Mannkind Corporation, Conor Medsystems, and Complete Genomics, Inc.
  • The underwriters of a US$345 million follow-on public offering of common stock of Pepco Holdings, Inc. coupled with an equity forward transaction

* These matters were completed while employed at another law firm.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.